Opaleye Management Inc. Protara Therapeutics, Inc. Transaction History
Opaleye Management Inc.
- $508 Million
- Q4 2024
A detailed history of Opaleye Management Inc. transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 1,825,000 shares of TARA stock, worth $7.59 Million. This represents 1.88% of its overall portfolio holdings.
Number of Shares
1,825,000
Previous 1,681,154
8.56%
Holding current value
$7.59 Million
Previous $3.08 Million
211.48%
% of portfolio
1.88%
Previous 0.56%
Shares
10 transactions
Others Institutions Holding TARA
# of Institutions
60Shares Held
23.4MCall Options Held
58.3KPut Options Held
110K-
Ra Capital Management, L.P. Boston, MA3.4MShares$14.1 Million0.29% of portfolio
-
Janus Henderson Group PLC London, X02.27MShares$9.45 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.25MShares$9.36 Million0.02% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A62.09MShares$8.69 Million0.02% of portfolio
-
Blackstone Inc New York, NY1.68MShares$6.99 Million0.04% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $46.9M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...